Vertex Pharmaceuticals Inc (VRTX):企業の財務・戦略的SWOT分析

◆英語タイトル:Vertex Pharmaceuticals Inc (VRTX) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15901
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Vertex Pharmaceuticals Inc (VRTX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Vertex Pharmaceuticals Inc (Vertex) is a biotechnology company that discovers, develops and commercializes transformative drugs for the treatment of serious and life-threatening diseases. The company product portfolio includes Orkambi (ivacaftor/lumacaftor) and Kalydeco (ivacaftor) for the treatment of cystic fibrosis (CF). Through its research and development (R&D) efforts, the company focuses on influenza, cancer, neurological diseases and disorders including pain and cystic fibrosis. Vertex has R&D centers and commercial offices in North America, South America, Europe and Australia. The company offers its products in the US, Europe, Australia and Canada. Vertex is headquartered in Boston, Massachusetts, the US.

Vertex Pharmaceuticals Inc Key Recent Developments

Apr 02,2019 Vertex Pharmaceuticals names Charles Wagner as Chief Financial Officer
Feb 21,2019 Vertex appoints Lloyd Carney to its board of directors
Feb 05,2019 Vertex reports full-year and fourth-quarter 2018 financial results
Jan 23,2019 Vertex announces departure of Ian Smith, names interim CFO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Vertex Pharmaceuticals Inc – Key Facts
Vertex Pharmaceuticals Inc – Key Employees
Vertex Pharmaceuticals Inc – Key Employee Biographies
Vertex Pharmaceuticals Inc – Major Products and Services
Vertex Pharmaceuticals Inc – History
Vertex Pharmaceuticals Inc – Company Statement
Vertex Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Vertex Pharmaceuticals Inc – Business Description
Business Segment: Pharmaceuticals
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Others
Performance
Geographical Segment: United States
Performance
R&D Overview
Vertex Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Vertex Pharmaceuticals Inc – Strengths
Vertex Pharmaceuticals Inc – Weaknesses
Vertex Pharmaceuticals Inc – Opportunities
Vertex Pharmaceuticals Inc – Threats
Vertex Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Vertex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Vertex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Vertex Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 02, 2019: Vertex Pharmaceuticals names Charles Wagner as Chief Financial Officer
Feb 21, 2019: Vertex appoints Lloyd Carney to its board of directors
Feb 05, 2019: Vertex reports full-year and fourth-quarter 2018 financial results
Jan 23, 2019: Vertex announces departure of Ian Smith, names interim CFO
Oct 24, 2018: Vertex reports third-quarter 2018 financial results
Oct 16, 2018: Vertex Pharmaceuticals selects Kinaxis to manage supply chain
Oct 10, 2018: CRISPR Therapeutics and Vertex Announce FDA Has Lifted the Clinical Hold on the Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease
Oct 04, 2018: Vertex’s cystic fibrosis drugs become publicly available in Denmark
Sep 10, 2018: Vertex Pharmaceuticals names Katharine Jensen as head of corporate social responsibility
Sep 06, 2018: Vertex Completes Enrollment of Two Phase 3 Studies of VX-659 in Triple Combination with Tezacaftor and Ivacaftor for the Treatment of Cystic Fibrosis[Newswire : Healthcare-BW]
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Vertex Pharmaceuticals Inc, Key Facts
Vertex Pharmaceuticals Inc, Key Employees
Vertex Pharmaceuticals Inc, Key Employee Biographies
Vertex Pharmaceuticals Inc, Major Products and Services
Vertex Pharmaceuticals Inc, History
Vertex Pharmaceuticals Inc, Subsidiaries
Vertex Pharmaceuticals Inc, Key Competitors
Vertex Pharmaceuticals Inc, Ratios based on current share price
Vertex Pharmaceuticals Inc, Annual Ratios
Vertex Pharmaceuticals Inc, Annual Ratios (Cont...1)
Vertex Pharmaceuticals Inc, Annual Ratios (Cont...2)
Vertex Pharmaceuticals Inc, Interim Ratios
Vertex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Vertex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Vertex Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Vertex Pharmaceuticals Inc, Performance Chart (2014 - 2018)
Vertex Pharmaceuticals Inc, Ratio Charts
Vertex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Vertex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Vertex Pharmaceuticals Inc (VRTX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MBIA Inc.:企業の戦略・SWOT・財務分析
    SummaryMBIA Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - De …
  • Karo Pharma AB (KARO):製薬・医療:M&Aディール及び事業提携情報
    Summary Karo Pharma AB (Karo Pharma), formerly Karo Bio AB, is a health care company that focuses on research and development of pharmaceutical products in the areas of cancer and autoimmune diseases. Its key research area involves nuclear receptors as target proteins for the development of new phar …
  • Veridian Corporation:発電所・企業SWOT分析
    Veridian Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • GTECH S.p.A. (formerly Lottomatica Group S.p.A.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' GTECH S.p.A. (formerly Lottomat …
  • Kuo Ching Chemical Co., Ltd. (1757):企業概要、財務及び戦略的SWOT分析
    Summary Kuo Ching Chemical Co., Ltd. (Kuo Ching) is a chemical company. The company manufactures and sells specialty chemicals. It offers polymer additives, flame retardants, elastomer, electronic chemicals, agrochemicals and sunkem sunscreens. Kuo Ching’s elastomer sectors include elastoplas TPV, k …
  • Pioneer Energy Services Corp. (PES):企業の財務及び戦略的SWOT分析
    Summary Pioneer Energy Services Corp. (Pioneer Energy) is a land contract drilling services provider that holds expertise in providing drilling and production services. The company offers wire-line services such as open-hole services and cased-hole services. Pioneer Energy’s well services include mu …
  • Dong Wha Pharma Co., Ltd. (000020):企業概要、財務及び戦略的SWOT分析
    Summary Dong wha Pharm Co., Ltd. (Dongwha Pharm) is a pharmaceutical company. The company carries out research, development, manufacture and marketing of healthcare products. It offers products through the divisions such as Ethical Drugs, Over-the-Counter (OTC) products, Health Subsidiary Foods, Med …
  • MBNA Ltd:企業の戦略・SWOT・財務情報
    MBNA Ltd - Strategy, SWOT and Corporate Finance Report Summary MBNA Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Beacon Biomedical Inc:企業のM&A・提携動向(医療機器分野)
    Summary Beacon Biomedical Inc (Beacon) is a medical diagnostic device company that provides accurate point-of-care blood tests to detect cancer easily. It offers its product portfolio in the therapeutic areas of breast cancer, colorectal cancer and lung cancer. The company holds two patented technol …
  • Galen Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Galen Ltd (Galen), a subsidiary of Almac Group Ltd is a marketer of pharmaceutical products. The company’s products include trustsaver, calceos, salivix, daunoxome, flotros, histofreezer, laxido, and saline steripoules, among others. It offers products in various therapy areas including angi …
  • Reval, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Reval, Inc. Mergers and Acquisi …
  • JFE Steel Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' JFE Steel Corporation Mergers a …
  • Henry Schein Inc (HSIC):企業の財務・戦略的SWOT分析
    Henry Schein Inc (HSIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • International Vaccine Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary International Vaccine Institute (IVI) is a non-profit organization that discovers, develops and delivers vaccines. The organization's vaccines include bivalent inactivated oral cholera vaccine, Vi-DT typhoid conjugate vaccine, bivalent typhoid conjugate vaccine, shigella vaccine, norovirus v …
  • Vattenfall AB:企業のM&A・提携動向(発電分野)
    Summary Vattenfall AB (Vattenfall) is a state-owned energy company that generates, distributes and sells electricity and heat. It is one of the leading generators of electricity and heat in Europe. The company also conducts the sale of gas and energy trading. Vattenfall generates power through vario …
  • Acrodea Inc. (3823):企業財務及び戦略的SWOT分析
    Summary Acrodea Inc. (Acrodea) is an information technology company that offers middleware business, platform solutions, content services and e-commerce business. The company’s middleware business line comprises consulting, contract development, and proprietary product development programs. Its medi …
  • EyeGene Inc (185490):企業財務及び戦略的SWOT分析
    Summary EyeGene Inc (EyeGene) is a biopharmaceutical company that develops therapeutics, diagnostics and technology. The company’s pipeline products include EG-decorin, EG-HPV, EG-mirotin, DRM and EGS. It provides functional genomics and information technology services, therapeutic and diagnostic co …
  • Ship Healthcare Holdings Inc (3360):企業財務及び戦略的SWOT分析
    Summary Ship Healthcare Holdings Inc (Ship Healthcare) is a diversified healthcare company that operates total pack produce, medical supply, healthcare and pharmacy businesses. The company offers medical materials and medical consumables for the medical facility. It also carried out SPD center relat …
  • Callidus Software Inc. (CALD):企業の財務及び戦略的SWOT分析
    Summary Callidus Software Inc. (Callidus) is an information technology company that provides cloud-based sales, marketing and learning solutions. The company’s products include territory and quota management, mobile learning, contract lifecycle management, sales coaching and others. Its services inc …
  • Popular, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Popular, Inc. Mergers and Acqui …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆